Bioactivity | broad-spectrum antiviral activity against enveloped viruses, including IAV, respiratory syncytial virus (RSV). anti-IAV effects in vitro and in vivo.;https://www.nature.com/articles/s41401-024-01331-7(J1);新品上线,张雨新分子推荐20240711 |
Invitro | Antiviral agent 58 (Compound J1) (6.25-200 μM; 48 h) 在 A549、MDCK、Vero-E6、HRT18 细胞中在 200μM 浓度下对细胞具有较低的细胞毒作用[1]。Antiviral agent 58 能抑制 H1N1、H7N9、H5N1 和 H3N2 等 IAV 毒株以及奥司他韦耐药 (HY-13317) 毒株的感染, IC50 值在 7.81-15.65 μM 之间[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Antiviral agent 58 相关抗体: |
In Vivo | Antiviral agent 58 (Compound J1) (15-60 mg/kg; 口服; 一天一次,连续 5 天) 在 BALB/c 小鼠中显著减轻 IAV 诱导的肺损伤[1]。model: IAV lung injury BALB/c mouse model[1].dose: 15 mg/kg; 30 mg/kg; 60 mg/kgadministration: Oral, once daily for 5 daysresult:Increased the survival rate of virus-infected mice, and decreased viral titer, lung index and lung inflammation damage. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: |
CAS | 939655-35-3 |
Formula | C24H18ClN3O |
Molar Mass | 399.87 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Li Y, et al. A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity[J]. Acta Pharmacologica Sinica, 2024: 1-14. |